Advaxis Inc. [NASDAQ: ADXS] traded at a low on 05/28/21, posting a -2.75 loss after which it closed the day’ session at $0.48. The company report on May 20, 2021 that Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting.
Updated data show disease control rate of 44% with durable clinical benefit observed beyond one year in patients with disease progression on pembrolizumab.
Translational data support potential of ADXS-503 to restore and/or enhance sensitivity to checkpoint inhibitors.
The results of the trading session contributed to over 7837716 shares changing hands. Over the past one week, the price volatility of Advaxis Inc. stands at 9.26% while the volatility over the past one month is 12.00%.
The market cap for ADXS stock reached $67.80 million, with 137.96 million shares outstanding and 119.41 million shares in the current float. Compared to the average trading volume of 10.02M shares, ADXS reached a trading volume of 7837716 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Advaxis Inc. [ADXS]?
Barclays have made an estimate for Advaxis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 03, 2016. While these analysts kept the previous recommendation, Barclays raised their target price to Overweight. The new note on the price target was released on September 22, 2015, representing the official price target for Advaxis Inc. stock. Previously, the target price had yet another raise to $30, while Guggenheim analysts kept a Buy rating on ADXS stock. On June 16, 2015, analysts increased their price target for ADXS shares from 25 to 30.
The Average True Range (ATR) for Advaxis Inc. is set at 0.06, with the Price to Sales ratio for ADXS stock in the period of the last 12 months amounting to 35.68. The Price to Book ratio for the last quarter was 1.06, with the Price to Cash per share for the same quarter was set at 0.23.
How has ADXS stock performed recently?
Advaxis Inc. [ADXS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.48. With this latest performance, ADXS shares dropped by -2.98% in over the last four-week period, additionally plugging by 66.03% over the last 6 months – not to mention a drop of -30.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADXS stock in for the last two-week period is set at 48.25, with the RSI for the last a single of trading hit 51.04, and the three-weeks RSI is set at 46.19 for Advaxis Inc. [ADXS]. The present Moving Average for the last 50 days of trading for this stock 0.5593, while it was recorded at 0.4626 for the last single week of trading, and 0.5495 for the last 200 days.
Advaxis Inc. [ADXS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Advaxis Inc. [ADXS] shares currently have an operating margin of -9337.55. Advaxis Inc.’s Net Margin is presently recorded at -10462.06.
Return on Total Capital for ADXS is now -62.39, given the latest momentum, and Return on Invested Capital for the company is -70.80. Return on Equity for this stock declined to -75.94, with Return on Assets sitting at -63.18. When it comes to the capital structure of this company, Advaxis Inc. [ADXS] has a Total Debt to Total Equity ratio set at 19.94. Additionally, ADXS Total Debt to Total Capital is recorded at 16.62, with Total Debt to Total Assets ending up at 15.62. Long-Term Debt to Equity for the company is recorded at 16.75, with the Long-Term Debt to Total Capital now at 13.97.
Reflecting on the efficiency of the workforce at the company, Advaxis Inc. [ADXS] managed to generate an average of -$1,470,500 per employee.Advaxis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.90 and a Current Ratio set at 9.90.
Earnings analysis for Advaxis Inc. [ADXS]
With the latest financial reports released by the company, Advaxis Inc. posted -0.15/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 51.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ADXS.
Insider trade positions for Advaxis Inc. [ADXS]
There are presently around $5 million, or 12.10% of ADXS stock, in the hands of institutional investors. The top three institutional holders of ADXS stocks are: VANGUARD GROUP INC with ownership of 3,900,361, which is approximately 380.824% of the company’s market cap and around 0.06% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 2,598,917 shares of the stock with an approximate value of $1.24 million in ADXS stocks shares; and BLACKROCK INC., currently with $0.64 million in ADXS stock with ownership of nearly 54.151% of the company’s market capitalization.
Positions in Advaxis Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 20 institutional holders increased their position in Advaxis Inc. [NASDAQ:ADXS] by around 4,477,200 shares. Additionally, 16 investors decreased positions by around 5,407,688 shares, while 10 investors held positions by with 137,433 shares. The mentioned changes placed institutional holdings at 10,022,321 shares, according to the latest SEC report filing. ADXS stock had 8 new institutional investments in for a total of 295,258 shares, while 8 institutional investors sold positions of 1,181,703 shares during the same period.